个人简介

完善中。

研究方向

脑胶质瘤分子病理的基础与临床研究

代表性论著

1. Wu, S., C. Luo, F. Li, N. U. F. Hameed, Q. Jin and J. Zhang (2019). “Silencing expression of PHF14 in glioblastoma promotes apoptosis, mitigates proliferation and invasiveness via Wnt signal pathway.” Cancer Cell Int 19: 314.
2. Wu, S., C. Luo, N. U. F. Hameed, Y. Wang and D. Zhuang (2020). “UCP2 silencing in glioblastoma reduces cell proliferation and invasiveness by inhibiting p38 MAPK pathway.” Exp Cell Res 394(1): 112110.
3. Wang, P., C. Luo, P. J. Hong, W. T. Rui and S. Wu (2021). “The Role of Surgery in IDH-Wild-Type Lower-Grade Gliomas: Threshold at a High Extent of Resection Should be Pursued.” Neurosurgery 88(6): 1136-1144.
4. Luo, C., K. Song, S. Wu, N. U. F. Hameed, N. Kudulaiti, H. Xu, Z. Y. Qin and J. S. Wu (2021). “The prognosis of glioblastoma: a large, multifactorial study.” Br J Neurosurg 35(5): 555-561.
5. Bu, L., N. U. F. Hameed, C. Luo, P. Hong, X. Zhou, S. Wang and S. Wu (2021). “Germline ALK variations are associated with a poor prognosis in glioma and IDH-wildtype glioblastoma.” J Neurooncol 152(1): 27-36.
6. Xiong, Z., C. Luo, P. Wang, N. U. F. Hameed, S. Song, X. Zhang, S. Wu, J. Wu and Y. Mao (2022). “The Intraoperative Utilization of Multimodalities Could Improve the Prognosis of Adult Glioblastoma: A Single-Center Observational Study.” World Neurosurg 165: e532-e545.
7. 罗宸, 吴帅, & 吴劲松. (2021). 分子病理指导下的脑胶质瘤手术的研究进展. 中华神经外科杂志, 37(9), 5.